Matches in SemOpenAlex for { <https://semopenalex.org/work/W3129332960> ?p ?o ?g. }
- W3129332960 endingPage "566" @default.
- W3129332960 startingPage "566" @default.
- W3129332960 abstract "Outbreaks of Ebola ebolavirus (EBOV) have been associated with high morbidity and mortality. Milestones have been reached recently in the management of EBOV disease (EVD) with licensure of an EBOV vaccine and two monoclonal antibody therapies. However, neither vaccines nor therapies are available for other disease-causing filoviruses. In preparation for such outbreaks, and for more facile and cost-effective management of EVD, we seek a cocktail containing orally available and room temperature stable drugs with strong activity against multiple filoviruses. We previously showed that (bepridil + sertraline) and (sertraline + toremifene) synergistically suppress EBOV in cell cultures. Here, we describe steps towards testing these combinations in a mouse model of EVD. We identified a vehicle suitable for oral delivery of the component drugs and determined that, thus formulated the drugs are equally active against EBOV as preparations in DMSO, and they maintain activity upon storage in solution for up to seven days. Pharmacokinetic (PK) studies indicated that the drugs in the oral delivery vehicle are well tolerated in mice at the highest doses tested. Collectively the data support advancement of these combinations to tests for synergy in a mouse model of EVD. Moreover, mathematical modeling based on human oral PK projects that the combinations would be more active in humans than their component single drugs." @default.
- W3129332960 created "2021-03-01" @default.
- W3129332960 creator A5002553313 @default.
- W3129332960 creator A5007106087 @default.
- W3129332960 creator A5008468726 @default.
- W3129332960 creator A5011843114 @default.
- W3129332960 creator A5014278257 @default.
- W3129332960 creator A5015766512 @default.
- W3129332960 creator A5018335496 @default.
- W3129332960 creator A5021701592 @default.
- W3129332960 creator A5021750523 @default.
- W3129332960 creator A5022884834 @default.
- W3129332960 creator A5023685580 @default.
- W3129332960 creator A5027357893 @default.
- W3129332960 creator A5031262013 @default.
- W3129332960 creator A5039002115 @default.
- W3129332960 creator A5039868592 @default.
- W3129332960 creator A5044366229 @default.
- W3129332960 creator A5048587779 @default.
- W3129332960 creator A5053240125 @default.
- W3129332960 creator A5058554329 @default.
- W3129332960 creator A5062741465 @default.
- W3129332960 creator A5077212519 @default.
- W3129332960 creator A5082104956 @default.
- W3129332960 creator A5085899840 @default.
- W3129332960 creator A5086574482 @default.
- W3129332960 creator A5091773218 @default.
- W3129332960 date "2021-03-10" @default.
- W3129332960 modified "2023-10-15" @default.
- W3129332960 title "Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo" @default.
- W3129332960 cites W1760776415 @default.
- W3129332960 cites W1987880456 @default.
- W3129332960 cites W1997279492 @default.
- W3129332960 cites W2043620814 @default.
- W3129332960 cites W2043829974 @default.
- W3129332960 cites W2044025814 @default.
- W3129332960 cites W2060221077 @default.
- W3129332960 cites W2077601386 @default.
- W3129332960 cites W2092973631 @default.
- W3129332960 cites W2106071934 @default.
- W3129332960 cites W2108356414 @default.
- W3129332960 cites W2110951885 @default.
- W3129332960 cites W2113132163 @default.
- W3129332960 cites W2113319733 @default.
- W3129332960 cites W2146117672 @default.
- W3129332960 cites W2150837053 @default.
- W3129332960 cites W2165629863 @default.
- W3129332960 cites W2177312905 @default.
- W3129332960 cites W2236504019 @default.
- W3129332960 cites W2256071216 @default.
- W3129332960 cites W2258642906 @default.
- W3129332960 cites W2268380397 @default.
- W3129332960 cites W2288648350 @default.
- W3129332960 cites W2292021561 @default.
- W3129332960 cites W2329393410 @default.
- W3129332960 cites W2342366514 @default.
- W3129332960 cites W2466466163 @default.
- W3129332960 cites W2541032267 @default.
- W3129332960 cites W2541382801 @default.
- W3129332960 cites W2556090342 @default.
- W3129332960 cites W2590932802 @default.
- W3129332960 cites W2599261484 @default.
- W3129332960 cites W2606690329 @default.
- W3129332960 cites W2736299457 @default.
- W3129332960 cites W2745108528 @default.
- W3129332960 cites W2749525663 @default.
- W3129332960 cites W2762941703 @default.
- W3129332960 cites W2776381475 @default.
- W3129332960 cites W2777797644 @default.
- W3129332960 cites W2779507963 @default.
- W3129332960 cites W2782060155 @default.
- W3129332960 cites W2783526431 @default.
- W3129332960 cites W2793533360 @default.
- W3129332960 cites W2794468699 @default.
- W3129332960 cites W2809885881 @default.
- W3129332960 cites W2847396516 @default.
- W3129332960 cites W2888415989 @default.
- W3129332960 cites W2891243125 @default.
- W3129332960 cites W2893315858 @default.
- W3129332960 cites W2898732423 @default.
- W3129332960 cites W2899671967 @default.
- W3129332960 cites W2901226061 @default.
- W3129332960 cites W2906490481 @default.
- W3129332960 cites W2914510228 @default.
- W3129332960 cites W2915527082 @default.
- W3129332960 cites W2936057480 @default.
- W3129332960 cites W2942019751 @default.
- W3129332960 cites W2944869471 @default.
- W3129332960 cites W2953861580 @default.
- W3129332960 cites W2964397977 @default.
- W3129332960 cites W2969518666 @default.
- W3129332960 cites W2991491848 @default.
- W3129332960 cites W2992826158 @default.
- W3129332960 cites W2996929230 @default.
- W3129332960 cites W3014708904 @default.
- W3129332960 cites W3026127770 @default.
- W3129332960 cites W3036370467 @default.
- W3129332960 cites W3045259741 @default.